专利信息

查询条件展开筛选条件

[药品] 包含 'Aprepitant'

首页上页 1 2 3 4 5 6 7 8 9 10 下页尾页共 116 条记录, 当前第5/12页。

	公开号	公开日	申请号	申请日

首页上页 1 2 3 4 5 6 7 8 9 10 下页尾页共 116 条记录, 当前第5/12页。

当前查询条件: [药品] 包含 'Aprepitant'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US8217039B2	2012/7/10
专利标题：Aprepitant polymorph mixtures 专利权人：Dr. Reddy's Laboratories, Inc.;dr. Reddy's Laboratories Ltd.; Intimate mixtures of aprepitant crystalline Form I and crystalline Form II having specific weight ratios of the forms.

2. CN102526740A	2012/7/4	CN2012132519	2012/2/14
专利标题：Novel high-efficiency antiemetic medicinal composition 专利权人：BEIJING FUKANGREN BIOPHARMACEUTICAL TECHNOLOGY CO LTD;

3. CN102525880A	2012/7/4	CN20101624215	2010/12/31
专利标题：Aprepitant solid dispersion composition 专利权人：JIANGSU CHIA TAI TIANQING PHAR;

4. CN102525879A	2012/7/4	CN20101624213	2010/12/31
专利标题：Method for preparing aprepitant solid dispersing composition 专利权人：JIANGSU CHIA TAI TIANQING PHAR;

5. CN102452996A	2012/5/16	CN20101527626	2010/11/1
专利标题：Novel preparation method of (2S,3R)-3-(4-fluorophenyl)-4-[(1R)-1-phenylethyl]-2-morpholinol hydrochloride 专利权人：LIN TAO;

6. CN102452944A	2012/5/16	CN20101523474	2010/10/27
专利标题：Novel method for preparing optically pure N-(1-phenyl ethyl) ethanolamine 专利权人：LIN TAO;

7. EP2445484A1	2012/5/2	EP20090776827	2009/6/24
专利标题：APREPITANT IN THE FORM OF A SOLID SOLUTION 专利权人：RATIOPHARM GMBH [DE];

8. TW201217366A	2012/5/1	TW20110134362	2011/9/23
专利标题：Aprepitant L-proline composition and cocrystal 专利权人：NUFORMIX LTD [GB]; A 1: 1: 1 aprepitant L-proline H2O composition and a 1: 1: 1 aprepitant L-proline H2O cocrystal are disclosed as well as pharmaceutical compositions containing a 1: 1: 1 aprepitant L-proline H2O composition or cocrystal and a pharmaceutically acceptable carrier. The 1: 1: 1 aprepitant L-proline H2O composition or cocrystal may be used in the same way as aprepitant to treat or prevent disorders relating to emesis, a neuropsychiatric disease, an inflammatory disease, pain, cancer, a skin disease, ...

9. EP2438061A1	2012/4/11	EP20100725285	2010/6/2
专利标题：PROCESS FOR THE PREPARATION OF CRYSTALLINE APREPITANT HAVING FORM I CONTENT 专利权人：RANBAXY LAB LTD [IN];

10. WO2012038937A1	2012/3/29	WO2011IB54210	2011/9/23
专利标题：APREPITANT L-PROLINE COMPOSITION AND COCRYSTAL 专利权人：NUFORMIX LTD [GB];HOLLAND JOANNE [GB];FRAMPTON CHRISTOPHER [GB];CHORLTON ALAN [GB];GOODING DANIEL [GB]; A 1:1:1 aprepitant L-proline H20 composition and a 1:1:1 aprepitant L-proline H20 cocrystal are disclosed as well as pharmaceutical compositions containing a 1:1:1 aprepitant L-prolirse H20 composition or cocrystai and a pharmaceutically acceptable carrier. The 1:1:1 aprepitant L-proline H20 composition or cocrystal may be used in the same way as aprepitant to treat or prevent disorders relating to emesis, a neuropsychiatric disease, an inflammatory disease, pairs, cancer, a skin disease, itch, ...

下载范围

下载内容